ACC: Novel IV Agent 'CHAMPION' Antiplatelet (CME/CE)

SAN FRANCISCO (MedPage Today) -- The novel fast-acting antiplatelet agent cangrelor given at the time of percutaneous coronary intervention (PCI) cuts ischemic complications better than clopidogrel (Plavix), the CHAMPION PHOENIX trial showed.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news